raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:799

Schizencephaly

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
All ages
Status
active

A rare developmental defect during embryogenesis characterized by the presence of linear clefts containing cerebrospinal fluid lined by abnormal grey matter that extend from the lateral ventricles to the pial surface of the cortex. Schizencephaly can involve one or both cerebral hemispheres and may lead to a variety of neurological symptoms such as epilepsy, motor deficits, and psychomotor retardation.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSchizencephaly
frSchizencéphalie
deSchizenzephalie
esEsquizencefalia
itSchizencefalia
nlSchizencefalie
ptEsquizencefalia
plSchizencefalia
csSchizencefalie
ukШизенцефалія
zh脑裂性孔洞脑
trşizensefali

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM269160Evalidated
ICD-10Q04.6NTBTinclusionvalidated
ICD-11LA05.61Especificvalidated
MONDO0010011Evalidated
MeSHD065707Evalidated
UMLSC0266484Evalidated
GARD166Evalidated
MedDRA10073487Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

Children (2):

4

Genes

0 direct · 4 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
COL4A1ORPHA:481986Familial schizencephalyDisease-causing germline mutation(s) inAssessedHGNC:2202ENSG0000018749812013013q34collagen type IV alpha 1 chain23225343[PMID]_25500781[PMID]_26576802[PMID]
EMX2ORPHA:485275Acquired schizencephalyMajor susceptibility factor inAssessedHGNC:3341ENSG0000017037060003510q26.11empty spiracles homeobox 28528262[PMID]_9153481[PMID]_9359037[PMID]_17506092[PMID]_17506092[PMID]
SHHORPHA:485275Acquired schizencephalyMajor susceptibility factor inAssessedHGNC:10848ENSG000001646906007257q36.3sonic hedgehog signaling molecule19533790[PMID]_20157829[PMID]
SIX3ORPHA:485275Acquired schizencephalyMajor susceptibility factor inAssessedHGNC:10889ENSG000001380836037142p21SIX homeobox 320157829[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0001.48 / 100 000United KingdomValue and classValidated21647999[PMID]
Prevalence at birth1-9 / 100 0001.54 / 100 000United StatesValue and classValidated16059942[PMID]
Point prevalenceUnknown—EuropeClass onlyNot yet validatedORPHANET
Prevalence at birth1-9 / 100 0001 / 100 000JapanValue and classValidated26545857[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

10 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0007370Aplasia/Hypoplasia of the corpus callosum
HP:0002353EEG abnormality
HP:0002132Porencephaly
HP:0001257Spasticity
HP:0000486Strabismus
Frequent (79-30%)
HP:0001263Global developmental delay
HP:0001269Hemiparesis
HP:0001249Intellectual disability
HP:0001250Seizure
HP:0002510Spastic tetraplegia

Run the differential on the 5 obligate / very frequent terms

7

Sources for this card